C. Santos

Phase II study of high-sensitivity genotyping of KRAS, NRAS, BRAF and PIK3CA to ultra-select metastatic colorectal cancer patients for panitumumab plus FOLFIRI: the ULTRA trial.

G. Capellá, R. Salazar, D. Páez, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

RET-fusions: a novel paradigm in colorectal cancer.

R. Sanz-Pamplona, R. Salazar, C. Santos, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Results of REARRANGE trial: A randomized phase 2 study comparing different dosing approaches for regorafenib (REG) during the first cycle of treatment in patients (pts) with metastatic colorectal cancer (mCRC).

J. Tabernero, F. Ciardiello, M. Valladares-Ayerbes, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Advanced age and liability to oxaliplatin‐induced peripheral neuropathy: post hoc analysis of a prospective study

G. Cavaletti, C. Briani, A. Argyriou, 2013, European Journal of Neurology.

Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients.

Cristina Santos, G. Cavaletti, C. Briani, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Prediction of pathological response to neoadjuvant treatment in rectal cancer with a two-protein immunohistochemical score derived from stromal gene-profiling

R. Sanz-Pamplona, J. Serra-Musach, G. Capellá, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Clinicopathological risk factors of Stage II colon cancer: results of a prospective study

E. Guinó, V. Moreno, R. Salazar, 2013, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer

R. Salazar, P. Nuciforo, J. Tabernero, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients.

G. Cavaletti, C. Briani, M. Cacciavillani, 2012 .

Evaluation of an abbreviated screening MRI protocol for patients at risk for hepatocellular carcinoma

J. Yee, S. Weinstein, T. Hope, 2018, Abdominal Radiology.